Pharmacological Management of Chemotherapy-Induced Nausea and Vomiting
- 1 January 2009
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 69 (5) , 515-533
- https://doi.org/10.2165/00003495-200969050-00002
Abstract
Chemotherapy-induced nausea and vomiting (CINV) is associated with a significant deterioration in quality of life. The emetogenicity of the chemotherapeutic agents, repeated chemotherapy cycles and...Keywords
This publication has 85 references indexed in Scilit:
- Palonosetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy for germ cell cancerSupportive Care in Cancer, 2007
- A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group studySupportive Care in Cancer, 2007
- Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity—an updateSupportive Care in Cancer, 2004
- Delayed emesis: moderately emetogenic chemotherapySupportive Care in Cancer, 2004
- Incidence of chemotherapy‐induced nausea and emesis after modern antiemeticsCancer, 2004
- AprepitantDrugs, 2004
- Antiemetic guidelines: creating a more practical treatment approachSupportive Care in Cancer, 2002
- Prevention of cisplatin‐induced acute and delayed emesis by the selective neurokinin‐1 antagonists, L‐758,298 and MK‐869Cancer, 2002
- Potential of Substance P Antagonists as AntiemeticsDrugs, 2000
- TropisetronDrugs, 2000